Shanghai Fosun Pharmaceutical (Group) 미래 성장
Future 기준 확인 3/6
Shanghai Fosun Pharmaceutical (Group) is forecast to grow earnings and revenue by 31.8% and 8.3% per annum respectively. EPS is expected to grow by 32.1% per annum. Return on equity is forecast to be 8.8% in 3 years.
주요 정보
31.8%
수익 성장률
32.1%
EPS 성장률
| Pharmaceuticals 수익 성장 | 19.3% |
| 매출 성장률 | 8.3% |
| 향후 자기자본 수익률 | 8.8% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 01 Nov 2024 |
최근 미래 성장 업데이트
Recent updates
Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Is Paying Out Less In Dividends Than Last Year
Aug 03
Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden
Jul 28Market Still Lacking Some Conviction On Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196)
May 23Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next
May 01We Think You Can Look Beyond Shanghai Fosun Pharmaceutical (Group)'s (SHSE:600196) Lackluster Earnings
Apr 02Is Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) A Risky Investment?
Mar 18Are Investors Undervaluing Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) By 48%?
Feb 26수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 49,202 | 4,466 | N/A | 5,976 | 5 |
| 12/31/2025 | 48,537 | 3,970 | N/A | 4,689 | 7 |
| 12/31/2024 | 41,612 | 2,808 | N/A | 3,725 | 2 |
| 9/30/2024 | 41,611 | 2,114 | -207 | 3,939 | N/A |
| 6/30/2024 | 40,467 | 1,835 | -976 | 3,511 | N/A |
| 3/31/2024 | 40,686 | 2,009 | -1,430 | 3,458 | N/A |
| 12/31/2023 | 41,400 | 2,386 | -1,922 | 3,414 | N/A |
| 9/30/2023 | 43,029 | 3,578 | -2,095 | 3,535 | N/A |
| 6/30/2023 | 43,999 | 3,972 | -2,007 | 4,229 | N/A |
| 3/31/2023 | 44,437 | 4,261 | -1,858 | 4,235 | N/A |
| 12/31/2022 | 43,952 | 3,731 | -1,671 | 4,218 | N/A |
| 9/30/2022 | 43,586 | 3,600 | -1,882 | 4,066 | N/A |
| 6/30/2022 | 43,406 | 3,782 | -1,252 | 4,030 | N/A |
| 3/31/2022 | 41,340 | 4,338 | -1,140 | 4,057 | N/A |
| 12/31/2021 | 39,011 | 4,729 | -1,035 | 3,938 | N/A |
| 9/30/2021 | 35,253 | 4,749 | -1,525 | 3,142 | N/A |
| 6/30/2021 | 33,231 | 4,430 | -1,994 | 2,825 | N/A |
| 3/31/2021 | 32,483 | 3,933 | -1,748 | 2,934 | N/A |
| 12/31/2020 | 30,307 | 3,663 | -1,857 | 2,580 | N/A |
| 9/30/2020 | 29,460 | 3,737 | -1,021 | 3,347 | N/A |
| 6/30/2020 | 28,441 | 3,520 | -592 | 3,234 | N/A |
| 3/31/2020 | 27,736 | 3,187 | -552 | 3,197 | N/A |
| 12/31/2019 | 28,585 | 3,322 | -740 | 3,222 | N/A |
| 9/30/2019 | 28,004 | 2,677 | -449 | 3,191 | N/A |
| 6/30/2019 | 27,232 | 2,664 | -893 | 3,122 | N/A |
| 3/31/2019 | 25,929 | 2,714 | -875 | 2,892 | N/A |
| 12/31/2018 | 24,918 | 2,708 | -225 | 2,950 | N/A |
| 9/30/2018 | 23,716 | 2,799 | -55 | 2,945 | N/A |
| 6/30/2018 | 22,040 | 2,996 | N/A | 2,755 | N/A |
| 3/31/2018 | 20,372 | 3,092 | N/A | 2,644 | N/A |
| 12/31/2017 | 18,534 | 3,124 | N/A | 2,580 | N/A |
| 9/30/2017 | 16,951 | 3,047 | N/A | 2,310 | N/A |
| 6/30/2017 | 16,045 | 2,993 | N/A | 2,278 | N/A |
| 3/31/2017 | 15,283 | 2,908 | N/A | 2,128 | N/A |
| 12/31/2016 | 14,629 | 2,805 | N/A | 2,110 | N/A |
| 9/30/2016 | 14,173 | 2,745 | N/A | 1,983 | N/A |
| 6/30/2016 | 13,624 | 2,657 | N/A | 1,880 | N/A |
| 3/31/2016 | 13,034 | 2,557 | N/A | 1,822 | N/A |
| 12/31/2015 | 12,609 | 2,459 | N/A | 1,621 | N/A |
| 9/30/2015 | 12,438 | 2,429 | N/A | 1,519 | N/A |
| 6/30/2015 | 12,408 | 2,398 | N/A | 1,474 | N/A |
| 3/31/2015 | 12,168 | 2,234 | N/A | 1,376 | N/A |
| 12/31/2014 | 12,026 | 2,113 | N/A | 1,200 | N/A |
| 9/30/2014 | 11,587 | 2,207 | N/A | 1,388 | N/A |
| 6/30/2014 | 11,026 | 1,987 | N/A | 1,104 | N/A |
| 3/31/2014 | 10,598 | 1,646 | N/A | 942 | N/A |
| 12/31/2013 | 9,996 | 1,583 | N/A | 1,012 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: 600196's forecast earnings growth (31.8% per year) is above the savings rate (2.9%).
수익 vs 시장: 600196's earnings (31.8% per year) are forecast to grow faster than the CN market (25.8% per year).
고성장 수익: 600196's earnings are expected to grow significantly over the next 3 years.
수익 대 시장: 600196's revenue (8.3% per year) is forecast to grow slower than the CN market (14% per year).
고성장 수익: 600196's revenue (8.3% per year) is forecast to grow slower than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: 600196's Return on Equity is forecast to be low in 3 years time (8.8%).